21089 ⎘
Medicinal preparations containing antigens or antibodies; Bacterial antigens; Enterobacteriales, e.g. Enterobacter Yersinia
COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE
#2IMMUNOGENICITY OF A CPG-ADJUVANTED RECOMBINANT PLAGUE VACCINE
#3THERMOSTABLE PARTICLE-BASED COMPOSITIONS AND MANUFACTURING PROCESS
#4IMPROVED CHIMERIC POLYPEPTIDES AND USES THEREOF
#5THERMOSTABLE UV INACTIVATED VACCINES AND OTHER BIOPHARMACEUTICALS
#6METHODS AND COMPOSITIONS RELATING TO IMMUNIZATION OF IMMUNE DISTINCT PATIENTS
#7METHODS AND COMPOSITIONS FOR MULTIVALENT VACCINES
#8SELF-ADJUVANTING YERSINIA OUTER MEMBRANE VESICLE AS A VACCINE AGAINST PLAGUE, ANTHRAX AND PSEUDOMONAS INFECTION
#9GUT BACTERIA DERIVED MICROVESICLES FOR VACCINE DELIVERY
#10A BROADLY PROTECTIVE PROPHYLACTIC VACCINE AGAINST PSEUDOMONAS AERUGINOSA
#11IMMUNOGENICITY OF A CPG-ADJUVANTED RECOMBINANT PLAGUE VACCINE
#12METHODS AND COMPOSITIONS RELATED TO THE NEXT GENERATION VACCINE
#13Self-adjuvanting outer membrane vesicle as a vaccine against plague, anthrax and pseudomonas infection
#14Gut bacteria derived microvesicles for vaccine delivery
#15IMMUNOMODULATORY & ONCOLYTIC MINICELLS AND METHODS OF USE
#16Immunotherapeutic potential of modified lipooligosaccharides/lipid A
#17Methods and compositions related to the next generation vaccine
#18NON-PSYCHOACTIVE CANNABINOIDS AS ADJUVANTS TO ENHANCE MUCOSAL IMMUNITY
#19Self-adjuvanting yersinia outer membrane vesicle as a vaccine against plague, anthrax and pseudomonas infection
#20Immunomodulatory minicells and methods of use
#21D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation
#22Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response
#23Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, bacillus anthracis and yersinia pestis
#24Immunotherapeutic potential of modified lipooligosaccharides/lipid A
#25Safe potent single platform vaccine against Tier 1 select agents and other pathogens
#26Immunomodulatory minicells and methods of use
#27Virulence attenuated bacteria for treatment of malignant solid tumors
#28METHODS TO IMPROVE INDUCTION OF IGG AND IGA ANTIBODIES BY VACCINES
#29Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, and
#30Immunomodulatory and oncolytic minicells and methods of use
#31Methods to improve induction of IgA antibodies by vaccines
#32Methods for treating plague
#33Oral administration of at least one pharmaceutical and/or antigenic active substance
#34Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens
#35spp. polypeptides and methods of use
#36Live-attenuated vaccine against plague
#37Immunomodulatory minicells and methods of use
#38Genetically modified as vaccines against species
#39spp. polypeptides and methods of use
#40Immunotherapeutic potential of modified lipooligosaccharides/lipid A
#41COMPOSITIONS, METHODS AND USES FOR EXPRESSION OF ENTEROBACTERIUM-ASSOCIATED PEPTIDES
#42spp. polypeptides and methods of use
#43Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens
#44Plague vaccine
#45typhi Ty21a expressing F1-V fusion protein and uses thereof
#46MULTIVALENT NANOEMULSION VACCINES
#47Bacterial vaccine
#48NOVEL METHOD FOR THE PREPARATION OF A STRAIN-ADAPTED VACCINE
#49Fusion protein for enhancing immunogenicity of bacterial antigen/immunogen
#50Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from as next generation plague vaccines
#51Modified pathogens for use as vaccines
#52Expression of Protective Antigens in Transgenic Chloroplasts and the Production of Improved Vaccines
#53spp. polypeptides and methods of use
#54spp. polypeptides and methods of use
#55spp. polypeptides and methods of use
#56Use of YSCF, truncated YSCF and YSCF homologs as adjuvants
#57Vaccine injection, preparation method and use thereof
#58USES OF YERSINIA YOPE PEPTIDE, GENE AND SUBPARTS THEREOF AS A PLAGUE VACCINE COMPONENT AND ASSAYS FOR YERSINIA PESTIS-SPECIFIC T CELLS
#59EXPRESSION OF PROTECTIVE ANTIGENS IN TRANSGENIC CHLOROPLASTS AND THE PRODUCTION OF IMPROVED VACCINES
#60antigens, vaccine compositions, and related methods
#61Compositions, methods and uses for expression of enterobacterium-associated peptides
#62IMMUNOGENIC COMPOSITIONS COMPRISING NANOEMULSION AND HEPATITIS B VIRUS IMMUNOGEN AND METHODS OF USING THE SAME
#63EXPRESSION OF PROTECTIVE ANTIGENS IN TRANSGENIC CHLOROPLASTS AND THE PRODUCTION OF IMPROVED VACCINES
#64Multivalent nanoemulsion vaccines
#65vaccine
#66Yersinia SPP. Polypeptides and Methods of Use
#67STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES
#68Anti-infective agents and uses thereof
#69antigens, vaccine compositions, and related methods
#70Use of flagellin in the immunotherapy of
#71Compositions and Methods Related to Adenovirus Based Delivery of Antigens
#72Modified pathogens for use as vaccines
#73Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same
#74STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES
#75Use of Flagellin in Tumor Immunotherapy
#76Use of flagellin in the immunotherapy of
#77Orally-administered live bacterial vaccines for plague
#78spp. polypeptides and methods of use
#79Antigen library immunization
#80Expression of protective antigens in transgenic chloroplasts
#81Multivalent DNA composition for